Has Kimberly Limbo received payments from drug or device companies?

Yes. Drug and device makers reported $43,135 in general payments to Kimberly Limbo across 785 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Limbo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Limbo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Limbo

Neurology with Special Qualifications in Child Neurology · Huntsville, ALNPI 1548479959

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,000 of the $43,135 with a category attached, or 64.9%. UCB, Inc. accounts for 81.1% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2024 at $16,866 and has fallen 54.1% since, to $7,736 in 2025. Among neurology with special qualifications in child neurology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,135in general payments, 2019–2025

Across 785 payments — averaging $54.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$35K
Neurelis, Inc.$2K
Supernus Pharmaceuticals, Inc.$1K
Jazz Pharmaceuticals Inc.$892
Acadia Pharmaceuticals Inc$530
Eisai Inc.$470
plus $3K from 30 others

What the payments were for

Speaking & faculty fees$28,00065%
Travel & lodging$2,4786%
Food & beverage$12,62829%
Education$290%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	289	$34,963
Neurelis, Inc.	89	$1,768
Supernus Pharmaceuticals, Inc.	201	$1,397
Jazz Pharmaceuticals Inc.	27	$892
Acadia Pharmaceuticals Inc	15	$530
Eisai Inc.	34	$470
Catalyst Pharmaceuticals, Inc.	20	$419
Livanova USA, Inc.	4	$387
Aquestive Therapeutics, Inc.	18	$334
Greenwich Biosciences, Inc.	6	$332
Sunovion Pharmaceuticals Inc.	17	$296
Aucta Pharmaceuticals, Inc.	7	$174
Sumitomo Pharma America, Inc.	7	$144
Corium, LLC	9	$128
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	2	$114
Immedica Pharma US, Inc.	4	$86
Tris Pharma Inc	5	$77
Biogen	3	$61
PTC Therapeutics, Inc.	2	$58
Upsher-smith Laboratories LLC	3	$52
Sarepta Therapeutics, Inc.	2	$49
Pyros Pharmaceuticals, Inc.	2	$41
Ipsen Biopharmaceuticals, Inc	2	$38
Zogenix Inc.	2	$35
Azurity Pharmaceuticals, Inc.	2	$35
Collegium Pharmaceutical, Inc.	2	$32
Intrabio Inc	1	$31
Travere Therapeutics, Inc.	2	$29
AbbVie	1	$29
ITF Therapeutics LLC	1	$22
Mallinckrodt Hospital Products Inc.	1	$22
Nobelpharma America, LLC	1	$20
AstraZeneca	1	$19
Ceribell, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$17
Saol Therapeutics Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Nayzilam$16,924
Briviact$13,540
VALTOCO$695
Epidiolex$604
VNS Therapy$327
DAYBUE$270
Fintepla$253

How this compares

$43,135 in reported general payments places this provider in the 90th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.

See all neurology with special qualifications in child neurology providers in Alabama →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OnfiClobazam	12	$40,362
TopamaxTopiramate	12	$14,156
DepakoteDivalproex Sodium	12	$4,255
Sertraline Hcl	23	$473
Levetiracetam	13	$244

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Huntsville

Joshua SmithHuntsville$4K
Brittney JonesHuntsville$2K
Alyssa ReddyBirmingham$68K
Alan PercyBirmingham$51K
Michael LopezBirmingham$22K
Elizabeth BebinBirmingham$15K
Amitha AnanthBirmingham$10K
Paul MaertensMobile$10K
Ahmad Al-HamdaMuscle Shoals$8K
Jan MathisenBirmingham$8K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →